Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia

dc.contributor.authorLipshitz, Melanie
dc.contributor.authorVisser, J.
dc.contributor.authorAnderson, Ronald
dc.contributor.authorNel, D.G.
dc.contributor.authorSmit, T.G. (Theunis)
dc.contributor.authorSteel, Helen Carolyn
dc.contributor.authorRapoport, Bernardo Leon
dc.date.accessioned2024-05-28T06:51:15Z
dc.date.available2024-05-28T06:51:15Z
dc.date.issued2024-05
dc.descriptionDATA AVAILABILITY : The data that support the findings of this study and related study tools are available from the corresponding author, Melanie Lipshitz (melanielevydietcian@gmail.com), upon reasonable request.en_US
dc.descriptionSUPPLEMENTARY MATERIAL : FIGURE S1. Functional assessment of anorexia / cachexia therapy (FAACTA/CS-12) categories. FIGURE S2. Cachexia categories for cases and controls. TABLE S1. European organisation for the research and treatment of cancer quality of life–C30 questionnaire (EORTC QLQ-C30) scores.en_US
dc.description.abstractPURPOSE : Quality of life (QoL), appetite, cachexia, and biomarkers [albumin, hemoglobin (Hb), neutrophils, lymphocytes, platelets, C-reactive protein (CRP), tumor necrosis factor alpha (TNFα), interleukin 6 (IL-6), interleukin 8 (IL-8), C-X-C motif chemokine ligand 5 (CXCL5) and citrullinated histoneH3 (H3Cit)] were compared for 40 cases with advanced cancer and 40 healthy controls. Baseline differences and significant relationships were explored for biomarkers with QoL, appetite, and cachexia. METHODS : In a prospective case–control, age and sex matched study, the European Organisation for the Research and Treatment of Cancer Quality of Life–C30 questionnaire (EORTC-QLQ-C30) for QoL, the Functional Assessment of Anorexia and Cachexia Therapy assessment (FAACT A/CS-12) for appetite, and a five-factor cachexia assessment tool for cachexia assessment were performed. Routine hematological measurements and blood chemistry analyses together with ELISA procedures and a Multiplex® bead array platform, were used for biomarker analysis. Descriptive statistics and regression analyses were undertaken. P < 0.05 defined statistical significance. RESULTS : Global health status (QL-G), functional scales (QL-FS), and symptom scales (QL-SS) differed for cases and controls (p < 0.01). In cases, differences were observed for QL-G (p < 0.01), QL-FS (p < 0.01), and QL-SS (p = 0.01) compared to standardized references values. FAACT A/CS-12 scores differed significantly between cases and controls (p < 0.01) and 30% of cases scored “poor” appetites. Cachexia was present in 60% of cases. Albumin, lymphocytes, platelets, Hb, platelet to lymphocyte ratio (PLR), systemic immune-inflammation index (SII), CRP, TNFα, all at p < 0.01, neutrophil to lymphocyte ratio (NLR) (p = 0.02), IL-6 (p < 0.04), and IL-8 (p = 0.02) differed significantly between cases and controls. No difference was found for CXCL5 or H3Cit. Albumin NLR, Hb, PLR, SII, TNFα, IL-8, and CRP showed significant relationships with all aspects of QoL. QL-FS was significantly related to CXCL5 (p = 0.04), significant relationships with FAACT A/CS-12 included: NLR (p = 0.002), Hb (p < 0.001), and PLR (p < 0.01). NLR, PLR, SII, TNFα, IL-6, IL-8, and CRP correlated positively to cachexia and albumin while Hb and lymphocyte count correlated negatively to cachexia. CONCLUSION : CXCL5 and H3Cit were not reliable biomarkers for cancer cachexia, nor significantly related to QoL, appetite or cachexia. Albumin, NLR, Hb, PLR, SII, TNFα, IL-8, and CRP were reliable indicators of QoL, appetite, and cachexia. Future research should include other novel biomarkers namely growth differentiation factor-15 (GDF-15), fibroblast growth factor 21 (FGF-21), fractakline, interferon gamma (IFN-y), IL-16, macrophage colony stimulating factor (M-CSF), and macrophage procoagulant–inducing factor (MPIF).en_US
dc.description.departmentImmunologyen_US
dc.description.librarianhj2024en_US
dc.description.sdgSDG-03:Good heatlh and well-beingen_US
dc.description.sponsorshipOpen access funding provided by Stellenbosch University. Partial financial support was received from the Harry Crossly Foundation.en_US
dc.description.urihttps://www.springer.com/journal/520en_US
dc.identifier.citationLipshitz, M., Visser, J., Anderson, R. et al. Relationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexia. Supportive Care in Cancer 32, 349 (2024). https://doi.org/10.1007/s00520-024-08549-5.en_US
dc.identifier.issn0941-4355 (print)
dc.identifier.issn1433-7339 (online)
dc.identifier.other10.1007/s00520-024-08549-5
dc.identifier.urihttp://hdl.handle.net/2263/96260
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.rights© The Author(s) 2024. Open Access. This article is licensed under a Creative Commons Attribution 4.0 International License.en_US
dc.subjectQuality of life (QoL)en_US
dc.subjectAnorexiaen_US
dc.subjectAppetiteen_US
dc.subjectBiomarkersen_US
dc.subjectCachexiaen_US
dc.subjectSDG-03: Good health and well-beingen_US
dc.titleRelationships of emerging biomarkers of cancer cachexia with quality of life, appetite, and cachexiaen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 4 of 4
Loading...
Thumbnail Image
Name:
Lipshitz_Relationships_2024.pdf
Size:
816.26 KB
Format:
Adobe Portable Document Format
Description:
Article
Loading...
Thumbnail Image
Name:
Lipshitz_RelationshipsFigS1_2024.pdf
Size:
63.56 KB
Format:
Adobe Portable Document Format
Description:
Figure S1
Loading...
Thumbnail Image
Name:
Lipshitz_RelationshipsFigS2_2024.pdf
Size:
69.63 KB
Format:
Adobe Portable Document Format
Description:
Figure S2
Loading...
Thumbnail Image
Name:
Lipshitz_RelationshipsTabS1_2024.pdf
Size:
56.08 KB
Format:
Adobe Portable Document Format
Description:
Table S1

License bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: